Skip to main content
Proceedings of the Royal Society B: Biological Sciences logoLink to Proceedings of the Royal Society B: Biological Sciences
. 2004 Feb 7;271(Suppl 3):S53–S56. doi: 10.1098/rsbl.2003.0088

Analysis of 'driver' and 'passenger' CD8+ T-cell responses against variable viruses.

Andreas Zafiropoulos 1, Eleanor Barnes 1, Clive Piggott 1, Paul Klenerman 1
PMCID: PMC1809984  PMID: 15101418

Abstract

Variable viruses, such as human immunodeficiency virus (HIV) and hepatitis C virus (HCV), persist despite host immune responses directed against them. Numerous lines of evidence have suggested that antiviral CD8+ T-cell responses are key among these immune responses, but these vary widely in their ability to contain virus. We propose that only a proportion of responses may exert significant antiviral pressure ('driver' responses), leading to control over viral replication (protection) and/or, ultimately, selection of escape mutants. Another set of responses may exert only weak pressure on the virus ('passenger' responses): these neither protect nor select. To examine this we have analysed (using established databases of HIV and HCV sequences and cytotoxic T-lymphocyte (CTL) epitopes, and published experimental datasets) two important features--predicted binding of the epitope to major histocompatibility complex molecule and observed variability of the epitope--that might distinguish such responses. We find that a high predicted binding estimate could only explain a limited set of 'driver' responses associated with protection or selection. There is statistical evidence that readily defined (and non-protective) CTL responses target regions associated with lower levels of viral variability. Taken together, this suggests that a large number of well-documented responses may represent 'passengers' and we propose a mechanism that might explain their presence.

Full Text

The Full Text of this article is available as a PDF (95.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altfeld Marcus, Allen Todd M., Yu Xu G., Johnston Mary N., Agrawal Deepak, Korber Bette T., Montefiori David C., O'Connor David H., Davis Ben T., Lee Paul K. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature. 2002 Nov 28;420(6914):434–439. doi: 10.1038/nature01200. [DOI] [PubMed] [Google Scholar]
  2. Carbone F. R., Bevan M. J. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med. 1990 Feb 1;171(2):377–387. doi: 10.1084/jem.171.2.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carrington Mary, O'Brien Stephen J. The influence of HLA genotype on AIDS. Annu Rev Med. 2001 Dec 3;54:535–551. doi: 10.1146/annurev.med.54.101601.152346. [DOI] [PubMed] [Google Scholar]
  4. Collins K. L., Chen B. K., Kalams S. A., Walker B. D., Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature. 1998 Jan 22;391(6665):397–401. doi: 10.1038/34929. [DOI] [PubMed] [Google Scholar]
  5. Goulder P. J., Phillips R. E., Colbert R. A., McAdam S., Ogg G., Nowak M. A., Giangrande P., Luzzi G., Morgan B., Edwards A. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med. 1997 Feb;3(2):212–217. doi: 10.1038/nm0297-212. [DOI] [PubMed] [Google Scholar]
  6. Klenerman Paul, Wu Ying, Phillips Rodney. HIV: current opinion in escapology. Curr Opin Microbiol. 2002 Aug;5(4):408–413. doi: 10.1016/s1369-5274(02)00339-9. [DOI] [PubMed] [Google Scholar]
  7. McMichael A. J., Ogg G., Wilson J., Callan M., Hambleton S., Appay V., Kelleher T., Rowland-Jones S. Memory CD8+ T cells in HIV infection. Philos Trans R Soc Lond B Biol Sci. 2000 Mar 29;355(1395):363–367. doi: 10.1098/rstb.2000.0575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Moore Corey B., John Mina, James Ian R., Christiansen Frank T., Witt Campbell S., Mallal Simon A. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science. 2002 May 24;296(5572):1439–1443. doi: 10.1126/science.1069660. [DOI] [PubMed] [Google Scholar]
  9. Ward S., Lauer G., Isba R., Walker B., Klenerman P. Cellular immune responses against hepatitis C virus: the evidence base 2002. Clin Exp Immunol. 2002 May;128(2):195–203. doi: 10.1046/j.1365-2249.2002.01840.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Willberg C., Barnes E., Klenerman P. HCV immunology--death and the maiden T cell. Cell Death Differ. 2003 Jan;10 (Suppl 1):S39–S47. doi: 10.1038/sj.cdd.4401122. [DOI] [PubMed] [Google Scholar]
  11. Yusim Karina, Kesmir Can, Gaschen Brian, Addo Marylyn M., Altfeld Marcus, Brunak Søren, Chigaev Alexandre, Detours Vincent, Korber Bette T. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J Virol. 2002 Sep;76(17):8757–8768. doi: 10.1128/JVI.76.17.8757-8768.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary data file
15101418supp.pdf (829.2KB, pdf)

Articles from Proceedings of the Royal Society B: Biological Sciences are provided here courtesy of The Royal Society

RESOURCES